Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Frassoni

Showing results (111-120 of 215) with videos related to

Pageof 22
Sort By:
British Journal of Haematology|March 1, 1995
Philadelphia-chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after a myelosuppressive chemotherapy in Philadelphia-chromosome-positive acute lymphoblastic leukaemiaA M Carella, F Frassoni, N Pollicardo, et al.
Bone Marrow Transplantation|April 1, 1990
Mixed chimerism after allogeneic marrow transplantation for leukaemia: correlation with dose of total body irradiation and graft-versus-host diseaseF Frassoni, P Strada, M Sessarego, et al.
British Journal of Haematology|September 21, 2001
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donorC L Balduini, F Frassoni, P Noris, et al.
Haematologica|September 1, 1983
[Autologous bone marrow transplantation without cryopreservation after megadoses of oncolytic chemotherapy. Pilot study in 18 cases]A M Carella, G Santini, F Frassoni, et al.
Leukemia|June 1, 1994
Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|December 1, 1989
Bone marrow transplantation for leukaemia: the role of total body irradiation, graft vs host disease, and haemopoietic chimerismA Bacigalupo, F Frassoni, M T Van Lint, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's diseaseA M Carella, G Santini, A Santoro, et al.
British Journal of Haematology|October 1, 1989
The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantationF Frassoni, D Scarpati, A Bacigalupo, et al.
Leukemia|June 1, 1991
Therapy of acute phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autotransplant and cyclosporine AA M Carella, E Gaozza, M R Raffo, et al.
Bone Marrow Transplantation|August 1, 1992
No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized studyA Gratwohl, J Hermans, A von Biezen, et al.
Pageof 22

Showing results (111-120 of 215) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|March 1, 1995
Philadelphia-chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after a myelosuppressive chemotherapy in Philadelphia-chromosome-positive acute lymphoblastic leukaemiaA M Carella, F Frassoni, N Pollicardo, et al.
Bone Marrow Transplantation|April 1, 1990
Mixed chimerism after allogeneic marrow transplantation for leukaemia: correlation with dose of total body irradiation and graft-versus-host diseaseF Frassoni, P Strada, M Sessarego, et al.
British Journal of Haematology|September 21, 2001
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donorC L Balduini, F Frassoni, P Noris, et al.
Haematologica|September 1, 1983
[Autologous bone marrow transplantation without cryopreservation after megadoses of oncolytic chemotherapy. Pilot study in 18 cases]A M Carella, G Santini, F Frassoni, et al.
Leukemia|June 1, 1994
Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|December 1, 1989
Bone marrow transplantation for leukaemia: the role of total body irradiation, graft vs host disease, and haemopoietic chimerismA Bacigalupo, F Frassoni, M T Van Lint, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's diseaseA M Carella, G Santini, A Santoro, et al.
British Journal of Haematology|October 1, 1989
The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantationF Frassoni, D Scarpati, A Bacigalupo, et al.
Leukemia|June 1, 1991
Therapy of acute phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autotransplant and cyclosporine AA M Carella, E Gaozza, M R Raffo, et al.
Bone Marrow Transplantation|August 1, 1992
No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized studyA Gratwohl, J Hermans, A von Biezen, et al.
Pageof 22